Schrödinger (NASDAQ:SDGR) Releases Quarterly Earnings Results, Misses Estimates By $0.20 EPS

Schrödinger (NASDAQ:SDGRGet Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.55) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.20), Zacks reports. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. Schrödinger updated its FY 2025 guidance to EPS.

Schrödinger Stock Up 3.1 %

Shares of NASDAQ SDGR traded up $0.65 during mid-day trading on Wednesday, hitting $21.70. 1,089,725 shares of the company were exchanged, compared to its average volume of 1,003,185. The stock has a 50 day simple moving average of $22.19 and a 200-day simple moving average of $20.55. Schrödinger has a 1-year low of $16.67 and a 1-year high of $33.63. The firm has a market cap of $1.58 billion, a price-to-earnings ratio of -9.27 and a beta of 1.61.

Wall Street Analyst Weigh In

A number of research analysts have commented on SDGR shares. BMO Capital Markets upped their target price on shares of Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. KeyCorp upped their target price on shares of Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Three analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $32.11.

View Our Latest Analysis on SDGR

Schrödinger Company Profile

(Get Free Report)

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

See Also

Earnings History for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.